10 April 2008 - 04:18
Genencor opening its Regional R&D Center in Shanghai, China
Danisco Site to host both Genencor sales, R&D, and Danisco Sales offices.
Shanghai, China, April 10, 2008 – Genencor, a division of Danisco A/S, today announced the opening of its state-of-the art R&D Center in Shanghai, China. The R&D Center is part of the overall expansion that Danisco is undertaking within Asia, with the Danisco Shanghai location as one of their premier new sites.
The prestigious Danisco Shanghai Center R&D facility is the latest addition to Genencor’s global R&D centres, presently located in the USA, Denmark, Finland, and the Netherlands. For both Genencor and Danisco, the opening of the Shanghai site marks an important strategic step towards establishing closer and dedicated ties to regional customers and their needs by providing them with tailor-made solutions.
“As a biotechnology leader, Genencor continues to invest in its world-wide innovation excellence for its customers, and now Genencor can provide this expertise in China as well,” says Mike Arbige, Executive Vice President of R&D at Genencor.
“In addition to having access to highly educated staff and first class universities, we also find a mature biotechnology network in China, which we can use to continually enhance our advantages in the field of enzyme discovery and protein engineering.”
“Since China is one of our strategic growth markets, we have been expanding our local operations considerably. We recently upgraded our manufacturing and applications plant in Wuxi, and now are proud to also offer R&D expertise to our regional customers,” said Gregory Rood, Vice President, Genencor China.
“Having the R&D center consolidated with the other parts of Danisco in one site in Shanghai will also strengthen the entire Danisco group’s value proposition to its customers. Our vision for the region is to bring Genencor’s world-class R&D expertise to the region and strive to be a leading biological and sustainable solution provider in China.”
|